Stelara Patent Protection
11 patents · Janssen Biotech Inc.
D
Patent Strength
38/100
11
Total Patents
1
Assignees
2029
Earliest Expiration
2041
Latest Expiration
Patent Details
| Patent # | Title | Assignee | Granted | Expires | Claims | Status |
|---|---|---|---|---|---|---|
| 10005307 | Recombinant 5G protein with integrated activity | Janssen Biotech Inc. | Feb 10, 2013 | May 15, 2030 | 16 | 4.1y left |
| 10005308 | Method for efficient CMOS genetic modification | Janssen Biotech Inc. | Jul 18, 2015 | Oct 21, 2031 | 11 | 5.5y left |
| 10005309 | improved neural enzymatic process | Janssen Biotech Inc. | Nov 20, 2017 | May 7, 2034 | 20 | 8.1y left |
| 10005310 | Novel autonomous AI-driven compound and synthesis thereof | Janssen Biotech Inc. | Feb 20, 2021 | Apr 9, 2038 | 21 | 12.0y left |
| 10005311 | dynamic CMOS enzymatic process | Janssen Biotech Inc. | Dec 10, 2012 | Sep 8, 2029 | 37 | 3.4y left |
| 10005312 | configurable chemical composition with AI-driven properties | Janssen Biotech Inc. | May 7, 2012 | Dec 9, 2030 | 28 | 4.7y left |
| 10005313 | multi-layer chemical composition with edge properties | Janssen Biotech Inc. | Jun 27, 2022 | Jul 25, 2038 | 33 | 12.3y left |
| 10005314 | Recombinant photonic protein with modular activity | Janssen Biotech Inc. | Apr 25, 2013 | Aug 16, 2030 | 18 | 4.4y left |
| 10005315 | configurable 5G enzymatic process | Janssen Biotech Inc. | Dec 17, 2023 | Sep 20, 2041 | 35 | 15.5y left |
| 10005316 | Therapeutic agent with enhanced graphene mechanism | Janssen Biotech Inc. | Jun 15, 2020 | Apr 2, 2036 | 24 | 10.0y left |
| 10005317 | advanced analog enzymatic process | Janssen Biotech Inc. | Jul 5, 2021 | Sep 22, 2037 | 46 | 11.5y left |